About Endomedix
Endomedix is a company based in Newark (United States) founded in 2005.. Endomedix has raised $1.99 million across 9 funding rounds from investors including NIH, HHS and Central Texas Angel Network. Endomedix offers products and services including PLEXimine™ Chemistry Platform. Endomedix operates in a competitive market with competitors including Prytime Medical Devices, Biom'Up, Abyrx, LifeBond and Surgrx, among others.
- Headquarter Newark, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Endomedix, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$1.99 M (USD)
in 9 rounds
-
Latest Funding Round
$500 K (USD), Seed
Jul 05, 2024
-
Investors
NIH
& 2 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Endomedix
Endomedix offers a comprehensive portfolio of products and services, including PLEXimine™ Chemistry Platform. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Enables formation of dynamic medical devices in situ for surgical enhancements.
Unlock access to complete
Unlock access to complete
Funding Insights of Endomedix
Endomedix has successfully raised a total of $1.99M across 9 strategic funding rounds. The most recent funding activity was a Seed round of $500 thousand completed in July 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 9
- Last Round Seed — $500,000
-
First Round
First Round
(28 Jul 2008)
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2024 | Amount | Seed - Endomedix | Valuation | Central Texas Angel Network |
|
| May, 2019 | Amount | Seed - Endomedix | Valuation |
investors |
|
| May, 2014 | Amount | Grant - Endomedix | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Endomedix
Endomedix has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include NIH, HHS and Central Texas Angel Network. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage investments are facilitated by Central Texas Angel Network.
|
Founded Year | Domain | Location | |
|
Public health and human services are overseen by HHS.
|
Founded Year | Domain | Location | |
|
Drug discovery services are provided to the biopharma sector.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Endomedix
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Endomedix
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Endomedix Comparisons
Competitors of Endomedix
Endomedix operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Prytime Medical Devices, Biom'Up, Abyrx, LifeBond and Surgrx, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of minimally invasive large vessel occludes for hemorrhage control in trauma patients
|
|
| domain | founded_year | HQ Location |
Hemostatic products for surgical applications are developed using collagen-based materials.
|
|
| domain | founded_year | HQ Location |
Hemostatic bone putty is developed for surgical bone bleeding control.
|
|
| domain | founded_year | HQ Location |
Absorbable surgical sealants and hemostats are developed for leakage prevention.
|
|
| domain | founded_year | HQ Location |
Tissue sealing and hemostasis systems are developed for laparoscopic surgery.
|
|
| domain | founded_year | HQ Location |
Shear-thinning biomaterial is developed to control blood flow minimally invasively.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Endomedix
When was Endomedix founded?
Endomedix was founded in 2005 and raised its 1st funding round 3 years after it was founded.
Where is Endomedix located?
Endomedix is headquartered in Newark, United States. It is registered at Newark, New Jersey, United States.
Is Endomedix a funded company?
Endomedix is a funded company, having raised a total of $1.99M across 9 funding rounds to date. The company's 1st funding round was a Grant of $1.49M, raised on Jul 28, 2008.
What does Endomedix do?
Endomedix was founded in 2005 and is based in Newark, United States. Hydrogel technology is developed by the company for medical device applications in tissue sealing, hemostasis, and biomedical adhesion. Products such as topical and internal hemostats, along with wound care options, are provided in forms including injectable liquids and lyophilized foams. Operations target surgery and wound management sectors.
Who are the top competitors of Endomedix?
Endomedix's top competitors include Prytime Medical Devices, Arch Therapeutics and Biom'Up.
What products or services does Endomedix offer?
Endomedix offers PLEXimine™ Chemistry Platform.
Who are Endomedix's investors?
Endomedix has 3 investors. Key investors include NIH, HHS, and Central Texas Angel Network.